由于Acinetobacter baumannii感染而引起的紫色膜溢出:一个罕见的病例报告
Sara Heidari1, Forough Kalantari2, Elham Kalantari3
1Department of Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Case reports in medicine
|October 15, 2025
概括
本病例报告详细介绍了一种罕见的紫色多流液 (PPE) 病例,由Acinetobacter baumannii感染引起. 不寻常的液体颜色,比如紫色的肺溢液,要求立即进行微生物学调查,以寻找潜在的感染.
科学领域:
- 医学 医学 医学 医学 医学
- 传染性疾病 传染性疾病
- 肺部病理学 肺部病理学
背景情况:
- 胸腔溢液 (PE) 是一个常见的临床问题,有多种原因,如心力衰竭,感染和癌症.
- 不寻常的胸腔液颜色可以提供关键的诊断线索,尽管很少用于诊断.
- 紫色流 (PPE) 是非常罕见的,全球只有少数记录的病例.
研究的目的:
- 报告一个罕见的紫色多流液 (PPE) 病例.
- 调查个人防护设备与Acinetobacter baumannii感染的关联.
- 探索个人防护设备的潜在病理生理学.
主要方法:
- 一个54岁男性的病例介绍,患有急性呼吸衰竭和右侧PE.
- 胸腔液特征和微生物培养的分析.
- 用胆固醇和美洛来治疗Acinetobacter baumannii感染的治疗.
主要成果:
- 患者出现呼吸衰竭和PE,最初显示淋巴细胞占主导地位的排泄性输液.
- 胸腔液逐渐变成深紫色,从导管和收集袋中分离出Acinetobacter baumannii.
- 患者在抗生素治疗后完全康复并消除了变色.
结论:
- 这一案例代表了与Acinetobacter baumannii相关的少数记录的个人防护品之一.
- 病理生理学可能涉及细菌代谢,类似于紫色尿囊综合征.
- 不寻常的胸腔液变色需要彻底的微生物学评估,即使没有典型的感染症状,也需要检测不常见或耐药的生物体.
更多相关视频
相关概念视频
01:28Pleural Effusion II: Symptoms and Management
652
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
652
01:30Pneumonia III: Complications and Assessment
786
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
786
01:25Pleural Effusion I: Introduction
3.9K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
3.9K
01:30Pneumonia I: Introduction
728
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
728
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
313
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
313
01:28Pneumonia IV: Management
754
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
754